Report Detail

Other Global (United States, European Union and China) Companion Diagnostic Market Research Report 2019-2025

  • RnM3574055
  • |
  • 19 July, 2019
  • |
  • Global
  • |
  • 110 Pages
  • |
  • QYResearch
  • |
  • Other

A companion diagnostic device is a special type of invitro medical device that provides information, which is necessary for the effective and safe use of an analogous drug or biological product. Companion diagnostics are developed simultaneously with drugs to help include or exclude a certain group of patients for treatment with a particular drug based on their biological characteristics, which determines patients who respond and those who dont respond to the therapy.
In 2019, the market size of Companion Diagnostic is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Companion Diagnostic.

This report studies the global market size of Companion Diagnostic, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Companion Diagnostic production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Abbott Laboratories
Agilent Technologies
Danaher Corporation
Illumina
Myriad Genetics
Qiagen
Roche
Thermo Fisher Scientific
Sysmex Corporation
Novartis

Market Segment by Product Type
Assay Kits
Reagents

Market Segment by Application
Pharmaceutical & Biopharmaceutical Companies
Laboratories
Other

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Companion Diagnostic status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Companion Diagnostic manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Companion Diagnostic are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Companion Diagnostic Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Assay Kits
      • 1.3.3 Reagents
    • 1.4 Market Segment by Application
      • 1.4.1 Global Companion Diagnostic Market Share by Application (2019-2025)
      • 1.4.2 Pharmaceutical & Biopharmaceutical Companies
      • 1.4.3 Laboratories
      • 1.4.4 Other
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Companion Diagnostic Production Value 2014-2025
      • 2.1.2 Global Companion Diagnostic Production 2014-2025
      • 2.1.3 Global Companion Diagnostic Capacity 2014-2025
      • 2.1.4 Global Companion Diagnostic Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Companion Diagnostic Market Size CAGR of Key Regions
      • 2.2.2 Global Companion Diagnostic Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Companion Diagnostic Capacity by Manufacturers
      • 3.1.2 Global Companion Diagnostic Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Companion Diagnostic Revenue by Manufacturers (2014-2019)
      • 3.2.2 Companion Diagnostic Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Companion Diagnostic Market Concentration Ratio (CR5 and HHI)
    • 3.3 Companion Diagnostic Price by Manufacturers
    • 3.4 Key Manufacturers Companion Diagnostic Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Companion Diagnostic Market
    • 3.6 Key Manufacturers Companion Diagnostic Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Assay Kits Production and Production Value (2014-2019)
      • 4.1.2 Reagents Production and Production Value (2014-2019)
    • 4.2 Global Companion Diagnostic Production Market Share by Type
    • 4.3 Global Companion Diagnostic Production Value Market Share by Type
    • 4.4 Companion Diagnostic Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Companion Diagnostic Consumption by Application

    6 Production by Regions

    • 6.1 Global Companion Diagnostic Production (History Data) by Regions 2014-2019
    • 6.2 Global Companion Diagnostic Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Companion Diagnostic Production Growth Rate 2014-2019
      • 6.3.2 United States Companion Diagnostic Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Companion Diagnostic Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Companion Diagnostic Production Growth Rate 2014-2019
      • 6.4.2 European Union Companion Diagnostic Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Companion Diagnostic Import & Export
    • 6.5 China
      • 6.5.1 China Companion Diagnostic Production Growth Rate 2014-2019
      • 6.5.2 China Companion Diagnostic Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Companion Diagnostic Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Companion Diagnostic Consumption by Regions

    • 7.1 Global Companion Diagnostic Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Companion Diagnostic Consumption by Type
      • 7.2.2 United States Companion Diagnostic Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Companion Diagnostic Consumption by Type
      • 7.3.2 European Union Companion Diagnostic Consumption by Application
    • 7.4 China
      • 7.4.1 China Companion Diagnostic Consumption by Type
      • 7.4.2 China Companion Diagnostic Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Companion Diagnostic Consumption by Type
      • 7.5.2 Rest of World Companion Diagnostic Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Abbott Laboratories
      • 8.1.1 Abbott Laboratories Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Companion Diagnostic
      • 8.1.4 Companion Diagnostic Product Introduction
      • 8.1.5 Abbott Laboratories Recent Development
    • 8.2 Agilent Technologies
      • 8.2.1 Agilent Technologies Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Companion Diagnostic
      • 8.2.4 Companion Diagnostic Product Introduction
      • 8.2.5 Agilent Technologies Recent Development
    • 8.3 Danaher Corporation
      • 8.3.1 Danaher Corporation Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Companion Diagnostic
      • 8.3.4 Companion Diagnostic Product Introduction
      • 8.3.5 Danaher Corporation Recent Development
    • 8.4 Illumina
      • 8.4.1 Illumina Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Companion Diagnostic
      • 8.4.4 Companion Diagnostic Product Introduction
      • 8.4.5 Illumina Recent Development
    • 8.5 Myriad Genetics
      • 8.5.1 Myriad Genetics Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Companion Diagnostic
      • 8.5.4 Companion Diagnostic Product Introduction
      • 8.5.5 Myriad Genetics Recent Development
    • 8.6 Qiagen
      • 8.6.1 Qiagen Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Companion Diagnostic
      • 8.6.4 Companion Diagnostic Product Introduction
      • 8.6.5 Qiagen Recent Development
    • 8.7 Roche
      • 8.7.1 Roche Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Companion Diagnostic
      • 8.7.4 Companion Diagnostic Product Introduction
      • 8.7.5 Roche Recent Development
    • 8.8 Thermo Fisher Scientific
      • 8.8.1 Thermo Fisher Scientific Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Companion Diagnostic
      • 8.8.4 Companion Diagnostic Product Introduction
      • 8.8.5 Thermo Fisher Scientific Recent Development
    • 8.9 Sysmex Corporation
      • 8.9.1 Sysmex Corporation Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Companion Diagnostic
      • 8.9.4 Companion Diagnostic Product Introduction
      • 8.9.5 Sysmex Corporation Recent Development
    • 8.10 Novartis
      • 8.10.1 Novartis Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Companion Diagnostic
      • 8.10.4 Companion Diagnostic Product Introduction
      • 8.10.5 Novartis Recent Development

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Companion Diagnostic Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Companion Diagnostic Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Companion Diagnostic Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Companion Diagnostic Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Companion Diagnostic Production Forecast by Type
      • 9.7.2 Global Companion Diagnostic Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Companion Diagnostic Sales Channels
      • 10.2.2 Companion Diagnostic Distributors
    • 10.3 Companion Diagnostic Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Summary:
      Get latest Market Research Reports on Companion Diagnostic . Industry analysis & Market Report on Companion Diagnostic is a syndicated market report, published as Global (United States, European Union and China) Companion Diagnostic Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Companion Diagnostic market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,587.92
      3,881.88
      5,175.84
      3,017.60
      4,526.40
      6,035.20
      508,957.60
      763,436.40
      1,017,915.20
      273,880.00
      410,820.00
      547,760.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report